Lichen planus pemphigoides during therapy with tislelizumab and sitravatinib in a patient with metastatic lung cancer
- 6 December 2019
- journal article
- letter
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 61 (2) , 180-182
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- PD-1 inhibitors induced bullous lichen planus-like reactions: a rare presentation and report of three casesMelanoma Research, 2016
- Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodiesCurrent Opinion in Oncology, 2016
- Pembrolizumab Cutaneous Adverse Events and Their Association With Disease ProgressionJAMA Dermatology, 2015
- Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapyBritish Journal of Dermatology, 2007